Affordable Access

188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.

Authors
  • Lambert, Bieke
  • Bacher, Klaus
  • De Keukeleire, Katrien
  • Smeets, Peter
  • Colle, Isabelle
  • Jeong, Jae Min
  • Thierens, Hubert
  • Troisi, Roberto
  • De Vos, Filip
  • Van de Wiele, Christophe
Type
Published Article
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Date
Aug 01, 2005
Volume
46
Issue
8
Pages
1326–1332
Identifiers
PMID: 16085590
Source
Medline
License
Unknown

Abstract

After the administration of 3.7 GBq (188)Re-HDD/lipiodol, half of the Child-Pugh B patients in the present study had a worsening of their general condition or aggravation of preexisting symptoms. This was associated with a rise in AFP in a considerable number of patients. In the future, administration of the radiopharmaceutical as close to the tumor feeding arteries as possible might avoid further deterioration of the liver function and show enhanced antitumoral activity.

Report this publication

Statistics

Seen <100 times